FDA Revised Benefit-Risk Criteria — Embracing Innovation
On March 27, 2012, the U.S. Food and Drug Administration released a final guidance document describing the principal factors the agency will consider when making benefit-risk determinations for medical devices subject...To view the full article, register now.
Already a subscriber? Click here to view full article